The report, in context
What this development means—and what it does not.
A systematic review published July 22, 2026 found preliminary signals that extracellular-vesicle therapies may improve wrinkle severity, pigmentation, hydration, elasticity or overall appearance in nonsurgical facial rejuvenation studies. The same review rated the evidence low to very low certainty and noted moderate-to-critical risk of bias, so this remains an emerging regenerative area that needs stronger trials before confident mainstream use.
Related Dagan MD pathways
Continue with the relevant clinical context.
Inclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.